RE: Production capacity20 Jun 2020 18:19
House broker finnCap said in May that the coronavirus test could potentially generate revenues of up to around £1.5mln per week.
This is based on partner Cytiva’s scalable manufacturing method, which is capable of producing 10,000 polymerase chain reaction (PCR) beads per hour.
Such revenues, which amount to £75mln on an annualised basis, could theoretically generate a gross margin of 60-80%